36.4
Bristol-Myers Squibb Company
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY21 to FY25
billions USD
FY21:
FY22:
36.0
FY23:
34.3
FY24:
34.3
FY25:
34.3
(positive)
Change from FY21 to FY25
billions USD
FY21:
8.10
FY22:
7.71
FY23:
8.20
FY24:
−8.38
FY25:
9.33
(positive)
Change from FY21 to FY24
billions USD
FY21:
20.4
FY22:
20.6
FY23:
19.3
FY24:
17.2
FY25:
–
(positive)
Change from FY21 to FY25
billions USD
FY21:
8.10
FY22:
7.71
FY23:
8.44
FY24:
−8.38
FY25:
9.33
(positive)
Change from FY21 to FY25
billions USD
FY21:
6.99
FY22:
6.33
FY23:
8.03
FY24:
−8.95
FY25:
7.05
All amounts in billions USD